J. W. R. Nortier

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Jean‐Marc Nabholtz, H.-J. Senn, W.R. Bezwoda et al. · Journal of Clinical Oncology · 1999 · 506 citations

Medicine, Oncology, Pharmacology +12

Aromatase and COX-2 expression in human breast cancers

A. Brodie, Qing Lü, Brian J. Long et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2001 · 151 citations

Medicine, Cancer Biology, Oncology +12

A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer

D. Rea, J. W. R. Nortier, W.W. ten Bokkel Huinink et al. · Annals of Oncology · 2005 · 80 citations

Medicine, Oncology, Pharmacology +15

Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third generation aromatase inhibitor vorozole

Paul C. de Jong, J. van de Ven, J. W. R. Nortier et al. · European Journal of Cancer · 1997 · 47 citations

Medicine, Oncology, Pharmacology +16

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)

Ayoub Charehbili, Saskia van de Ven, Vincent T.H.B.M. Smit et al. · Annals of Oncology · 2014 · 38 citations · Full text

Medicine, Oncology, Pharmacotherapy +15